Evaluation of Syndecan-1 Expression in Iraqi Patients with Papillary Thyroid Carcinoma

Abstract

Papillary thyroid carcinoma (PTC) represents the most prevalent kind of thyroid gland cancer, making up around 80% of all occurrences of thyroid cancer. Evidence shows that Syndecan-1 (SDC-1) expression is lost in a number of benign and malignant epithelial neoplasms, although its expression profile in thyroid gland neoplasms is yet unknown. Therefore, the aim of this study was to assess SDC-1 expression in papillary thyroid carcinoma patients, as well as the relationship between age and gender and SDC-1 expression. To undertake a detailed investigation of SDC-1 in normal and malignant tissues, tissue sections were used to examine SDC-1 expression in 70 tissue samples, 50 distinct PTC (6 males and 44 females) and 20 normal tissue types (10 from each gender) as control. Ages in each group ranged from 20 to 60 years. The results showed a statistically different level of SDC-1 expression in patients and control. There was no significant relationship between SDC-1 expression and gender or age,  in accordance with recent research findings which suggest that SDC- 1 might be exploited as a prognostic indicator or a target in cancer treatment in the future.